Form 4: Guardant Health CLO Saia Boosts Stake Post-RSU Vesting

Guardant Health's Chief Legal Officer, John G. Saia, increased his direct beneficial ownership of common stock to 52,168 shares following the vesting of restricted stock units and subsequent tax-related sales.

Summary

• John G. Saia, Chief Legal Officer of Guardant Health, Inc. (GH), reported transactions on October 1, 2025, related to his equity compensation.
• Saia acquired a total of 14,167 shares of common stock through the vesting of restricted stock units (RSUs).
• These vested shares originated from RSU awards granted on November 7, 2022 (974 shares vested), December 13, 2023 (1,668 shares vested), and November 8, 2024 (11,525 shares vested).
• Concurrently, 7,431 shares were disposed of by the company at a price of $62.65 per share to cover tax withholding obligations associated with the RSU vesting.
• Following these transactions, Saia's direct beneficial ownership of Guardant Health common stock stands at 52,168 shares.
• Remaining unvested Restricted Stock Units include 3,896 from the November 7, 2022 grant, 6,669 from the December 13, 2023 grant, and 23,401 from the November 8, 2024 grant.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of restricted stock units and subsequent tax-related sales. This is a neutral event, reflecting standard executive compensation practices without indicating any significant positive or negative operational or financial developments for the company.

Positives

• The Chief Legal Officer increased his direct beneficial ownership of common stock by a net of 6,736 shares (14,167 acquired minus 7,431 sold for tax), indicating continued alignment with shareholder interests.
• The vesting of restricted stock units demonstrates the company's commitment to long-term incentive plans for its executives.

Negatives

• A portion of the vested shares (7,431 shares) was sold to cover tax withholding obligations, which is a common practice but reduces the immediate increase in direct ownership.

Future Outlook

NA

Management Comments

• These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, specifically the vesting of restricted stock units and subsequent tax withholding. Such transactions are common across all industries for publicly traded companies that utilize equity-based compensation to incentivize and retain key personnel. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The increase in direct beneficial ownership by a key executive aligns his interests with shareholders, though the overall impact on share price from a routine vesting is minimal.
• Employees: Reflects the company's ongoing use of equity compensation, which can be a positive for employee retention and motivation.

Next Steps

• Remaining unvested restricted stock units will continue to vest in equal quarterly installments over the remaining two to three-year periods, depending on the original grant date.

Key Dates

Keywords

Guardant Health, GH, John G. Saia, Chief Legal Officer, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Stock Ownership, Executive Compensation